Search

Search Constraints

You searched for: Author/Creator Robain, Mathieu

Search Results

2. Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study. (September 2019)

3. Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008–2016. (April 2020)

4. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME MBC COHORT. (October 2018)

5. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. (August 2020)

6. Impact of body mass index on overall survival in patients with metastatic breast cancer. (February 2021)

7. Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program. (April 2021)

8. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. (April 2020)

9. Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. Issue 12 (20th June 2019)